Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.38 |
| ▸ | AHR | P35869 | 4/20 | 0.38 |
| ▸ | CFTR | P13569 | 1/20 | 0.34 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 2/20 | 0.33 |
| ▸ | MAOB | P27338 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.31 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PNMT | P11086 | 1/20 | 0.30 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.30 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.30 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21880277 | 0.83 | LMNA (0.37) | ALOX5AHRMAOALMNA | |
| SCHEMBL11453271 | 0.81 | CFTR (0.37) | CFTRGOPCMAOAMAOBP2RX4 | |
| SCHEMBL9407348 | 0.80 | ATM (0.39) | MAOAMAOBP2RX4 | |
| SCHEMBL5467986 | 0.77 | GAA (0.36) | MAOAMAOBLMNAMEN1NPC1 | |
| SCHEMBL4388225 | 0.77 | ALOX5 (0.41) | ALOX5AHRCFTRGOPCMAOA | |
| SCHEMBL8984710 | 0.77 | ALOX5 (0.44) | ALOX5AHRMAOAMAOBCHRM3 | |
| SCHEMBL23028838 | 0.76 | LMNA (0.39) | ALOX5AHRCFTRGOPCMAOA | |
| SCHEMBL11510200 | 0.75 | S100A4 (0.45) | CFTRGOPCLMNAMEN1RAB9A | |
| SCHEMBL896505 | 0.74 | PNMT (0.39) | ALOX5AHRCFTRGOPCMAOA | |
| SCHEMBL7031351 | 0.74 | ALOX5 (0.38) | ALOX5AHRCFTRGOPCMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113683631-A | Organic boric acid glucose probe and preparation method and application thereof | 王凯 | 2021-11-23 | — | — | CN | claimed |
| US-5663030-A | A PHENYL OR NORBORNANE DERIVATIVE AS AN ADDITIVE TO REDUCE HEAT AND ENERGY REQUIRED TO FUSE THE TONER AND TO REDUCE JAMMING OF THE EQUIPMENT | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| CN-113683631-B | Organic boric acid glucose probe and preparation method and application thereof | 王凯 | 2023-01-17 | — | — | CN | disclosed |
| US-11390643-B2 | Modified oligonucleotides comprising thiol functions and use thereof for detecting nucleic acids | ETABLISSEMENT FRANÇAIS DU SANG (FR) | 2022-07-19 | — | — | US | disclosed |
| CN-113683631-A | Organic boric acid glucose probe and preparation method and application thereof | 王凯 | 2021-11-23 | — | — | CN | disclosed |
| US-11078229-B2 | Thiol compounds and the use thereof for the synthesis of modified oligonucleotides | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2021-08-03 | — | — | US | disclosed |
| US-20180265538-A1 | THIOL COMPOUNDS AND THE USE THEREOF FOR THE SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2018-09-20 | — | — | US | disclosed |
| US-9896473-B2 | Thiol compounds and the use thereof for the synthesis of modified oligonucleotides | ETABLISSEMENT FRANCAIS DU SANG (FR) | 2018-02-20 | — | — | US | disclosed |
| US-20150232957-A1 | MODIFIED OLIGONUCLEOTIDES COMPRISING THIOL FUNCTIONS AND USE THEREOF FOR DETECTING NUCLEIC ACIDS | ETABLISSEMENT FRANÇAIS DU SANG (FR) | 2015-08-20 | — | — | US | disclosed |
| US-20150158964-A1 | THIOL COMPOUNDS AND THE USE THEREOF FOR THE SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES | UNIVERSITE CLAUDE BERNARD LYON 1 (FR) | 2015-06-11 | — | — | US | disclosed |
| US-8785419-B2 | Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2014-07-22 | — | — | US | disclosed |
| US-5387725-A | Chlorinating compounds having acidic protons with a perchloro-alkane and aqueous base in the presence of a tetraalkyl-ammonium hydroxide phase transfer catalyst | THE DOW CHEMICAL COMPANY (US) | 1995-02-07 | — | — | US | disclosed |
| CN-1098107-A | modified oligodeoxynucleotides, their preparation and their therapeutic use | SANKYO CO (JP) | 1995-02-01 | — | — | CN | disclosed |
| EP-0624372-A2 | Medicament for treating human immunodeficiency virus | NIPPON CHEMIPHAR CO., LTD. (JP) | 1994-11-17 | — | — | EP | disclosed |
| EP-0617046-A1 | Nucleoside derivatives and antiherpes composition | NIPPON CHEMIPHAR CO., LTD. (JP) | 1994-09-28 | — | — | EP | disclosed |
| EP-0611366-A1 | CHLORINATION PROCESS, ALKYLATION OF PRODUCTS OF SAID PROCESS AND SOME PRODUCTS THEREOF | THE DOW CHEMICAL COMPANY (US) | 1994-08-24 | — | — | EP | disclosed |
| EP-0611075-A1 | Modified oligodeoxyribonucleotides, their preparation and their therapeutic use | SANKYO COMPANY LIMITED (JP) | 1994-08-17 | — | — | EP | disclosed |
| WO-1993024511-A1 | OLIGONUCLEOTIDE-POLYAMIDE CONJUGATES | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 1993-12-09 | — | — | WO | disclosed |
| WO-1993009074-A2 | CHLORINATION PROCESS, ALKYLATION OF PRODUCTS OF SAID PROCESS AND SOME PRODUCTS THEREOF | THE DOW CHEMICAL COMPANY (US) | 1993-05-13 | — | — | WO | disclosed |
| EP-0513358-A1 | PROCESS FOR PRODUCING CYCLODEXTRIN DERIVATIVE AND POLYMER CONTAINING CYCLODEXTRIN IMMOBILIZED THEREIN | Toppan Printing Co., Ltd. (JP) | 1992-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150158964-A1 | THIOL COMPOUNDS AND THE USE THEREOF FOR THE SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES | TST, APEX1, TMT1A | ALOX5 956/4885AHR 3265/4885CFTR 3167/4885 |
| US-11390643-B2 | Modified oligonucleotides comprising thiol functions and use thereof for detecting nucleic acids | DNAJC10, TIMCC, TST | ALOX5 4140/4885AHR 3099/4885CFTR 956/4885 |
| US-20180265538-A1 | THIOL COMPOUNDS AND THE USE THEREOF FOR THE SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES | TST, APEX1, TMT1A | ALOX5 956/4885AHR 3265/4885CFTR 3167/4885 |
| US-11078229-B2 | Thiol compounds and the use thereof for the synthesis of modified oligonucleotides | TST, APEX1, TMT1A | ALOX5 956/4885AHR 3265/4885CFTR 3167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.